“Real World” Studies Monitor The Effects of New Pulmonary Arterial Hypertension Drugs
oracast / Pixabay

“Real World” Studies Monitor The Effects of New Pulmonary Arterial Hypertension Drugs

According to a story from MD Magazine, researchers are using real-world studies, outside of the controls found in the clinical setting, to trace the impacts of multiple recently approved therapies…

Continue Reading “Real World” Studies Monitor The Effects of New Pulmonary Arterial Hypertension Drugs
A Woman with Sickle Cell Disease Has Created a Foundation to Support Others with the Condition
allinonemovie / Pixabay

A Woman with Sickle Cell Disease Has Created a Foundation to Support Others with the Condition

The Noah’s Ark Foundation For Sickle Cell, an NGO based in Lagos, Nigeria, is working to support people with sickle cell disease. In a recent interview with the Nigerian Tribune,…

Continue Reading A Woman with Sickle Cell Disease Has Created a Foundation to Support Others with the Condition
A Greater Number of Drugs Are Getting Cleared With the FDA’s Accelerated Approval. What Does This Mean?
harshahars / Pixabay

A Greater Number of Drugs Are Getting Cleared With the FDA’s Accelerated Approval. What Does This Mean?

According to a story from Boston Health News, The US Food and Drug Administration's Accelerated Approval program is being used to approve a steadily growing number of drugs in recent…

Continue Reading A Greater Number of Drugs Are Getting Cleared With the FDA’s Accelerated Approval. What Does This Mean?
Rare Disease and Personal Identity: Why This Hemophilia Patient Isn’t Interested in a Cure
SoFuego / Pixabay

Rare Disease and Personal Identity: Why This Hemophilia Patient Isn’t Interested in a Cure

According to a story from The Atlantic, the continual development of gene editing technologies like CRISPR have the potential to cure a substantial portion of rare diseases that are linked…

Continue Reading Rare Disease and Personal Identity: Why This Hemophilia Patient Isn’t Interested in a Cure
Encouraging Topline Data has Been Shared From a Phase 3 Study of a Drug for Acute Hepatic Porphyria
source: pixabay.com

Encouraging Topline Data has Been Shared From a Phase 3 Study of a Drug for Acute Hepatic Porphyria

Topline results have been shared from a Phase 3 study of the investigational drug givosiran in patients with acute hepatic porphyria. For more detailed information you can view the source…

Continue Reading Encouraging Topline Data has Been Shared From a Phase 3 Study of a Drug for Acute Hepatic Porphyria
Shriners Hospitals for Children® are Using Motion Analysis Centres to Help Understand Patients’ Movements
geralt / Pixabay

Shriners Hospitals for Children® are Using Motion Analysis Centres to Help Understand Patients’ Movements

Shriners Hospitals for Children® has announced their motion analysis centre consortium. The hospital’s Motion Analysis Centre is used to evaluate the movements and gait of children and teenagers. To read about…

Continue Reading Shriners Hospitals for Children® are Using Motion Analysis Centres to Help Understand Patients’ Movements
A Widely Used Antifungal Drug Could be Effective For Treating Congenital Erthropoietic Porphyria
Alexas_Fotos / Pixabay

A Widely Used Antifungal Drug Could be Effective For Treating Congenital Erthropoietic Porphyria

According to a story from Medical Xpress, an international group of scientists from the US, France, and Spain may have discovered that an antifungal agent commonly used to treat skin…

Continue Reading A Widely Used Antifungal Drug Could be Effective For Treating Congenital Erthropoietic Porphyria
Innovative Program in Greenville, SC Helps Patients With Sickle Cell Anemia
StockSnap / Pixabay

Innovative Program in Greenville, SC Helps Patients With Sickle Cell Anemia

According to a story from Greenville Online, the Greenville Health System has begun implementing a comprehensive treatment program for patients with sickle cell disease and its most severe and common…

Continue Reading Innovative Program in Greenville, SC Helps Patients With Sickle Cell Anemia
Clinical Trial Data Looking Promising for an Experimental Amyotrophic Lateral Sclerosis Treatment
DarkoStojanovic / Pixabay

Clinical Trial Data Looking Promising for an Experimental Amyotrophic Lateral Sclerosis Treatment

According to a story from BioSpace, the biotechnology company BioElectron recently announced that the results from its Phase 2a clinical trial of its experimental product EPI-589 are looking positive. EPI-589…

Continue Reading Clinical Trial Data Looking Promising for an Experimental Amyotrophic Lateral Sclerosis Treatment